Consolidated Planning Corp Buys 1,870 Shares of Aflac Incorporated (NYSE:AFL)

Consolidated Planning Corp raised its stake in shares of Aflac Incorporated (NYSE:AFL) by 2.4% in the first quarter, according to the company in its most recent disclosure with the SEC. The firm owned 79,883 shares of the financial services provider’s stock after acquiring an additional 1,870 shares during the quarter. Aflac makes up 1.2% of Consolidated Planning Corp’s portfolio, making the stock its 21st largest holding. Consolidated Planning Corp’s holdings in Aflac were worth $8,882,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Whipplewood Advisors LLC bought a new position in shares of Aflac in the fourth quarter valued at about $26,000. BankPlus Trust Department bought a new position in shares of Aflac in the fourth quarter valued at about $34,000. Curio Wealth LLC bought a new position in shares of Aflac in the fourth quarter valued at about $36,000. Garde Capital Inc. bought a new position in shares of Aflac in the first quarter valued at about $36,000. Finally, OFI Invest Asset Management bought a new position in shares of Aflac in the fourth quarter valued at about $38,000. 67.44% of the stock is owned by institutional investors.

Analysts Set New Price Targets

AFL has been the subject of a number of research analyst reports. Piper Sandler lifted their price target on Aflac from $118.00 to $124.00 and gave the company an “overweight” rating in a report on Wednesday, April 2nd. Raymond James Financial lowered their price objective on Aflac from $115.00 to $110.00 and set an “outperform” rating for the company in a research report on Thursday, May 29th. Wells Fargo & Company lifted their price objective on Aflac from $102.00 to $103.00 and gave the stock an “equal weight” rating in a research report on Tuesday, May 6th. UBS Group lifted their price objective on Aflac from $109.00 to $114.00 and gave the stock a “neutral” rating in a research report on Wednesday, April 2nd. Finally, Barclays lifted their price objective on Aflac from $95.00 to $96.00 and gave the stock an “underweight” rating in a research report on Thursday, May 1st. Three research analysts have rated the stock with a sell rating, ten have given a hold rating and three have issued a buy rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Hold” and an average target price of $104.93.

Insider Buying and Selling at Aflac

In related news, Director Arthur Reginald Collins sold 2,750 shares of the stock in a transaction on Thursday, May 15th. The stock was sold at an average price of $105.70, for a total value of $290,675.00. Following the sale, the director now owns 6,728 shares in the company, valued at approximately $711,149.60. This represents a 29.01% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Masatoshi Koide sold 37,000 shares of the company’s stock in a transaction on Tuesday, May 20th. The shares were sold at an average price of $105.59, for a total value of $3,906,830.00. Following the completion of the transaction, the director now directly owns 70,992 shares in the company, valued at approximately $7,496,045.28. This represents a 34.26% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders have sold 40,750 shares of company stock worth $4,304,295. Corporate insiders own 0.80% of the company’s stock.

Aflac Price Performance

Aflac stock opened at $103.31 on Monday. The firm has a market capitalization of $55.85 billion, a P/E ratio of 16.14, a PEG ratio of 3.20 and a beta of 0.82. Aflac Incorporated has a 1 year low of $88.00 and a 1 year high of $115.50. The business has a 50-day moving average of $104.91 and a 200-day moving average of $105.24. The company has a current ratio of 0.09, a quick ratio of 0.09 and a debt-to-equity ratio of 0.29.

Aflac (NYSE:AFL) last issued its quarterly earnings data on Wednesday, April 30th. The financial services provider reported $1.66 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.67 by ($0.01). Aflac had a net margin of 21.27% and a return on equity of 15.55%. The business had revenue of $3.40 billion during the quarter, compared to analyst estimates of $4.53 billion. During the same quarter in the prior year, the firm posted $1.66 earnings per share. Aflac’s revenue for the quarter was down 37.5% compared to the same quarter last year. On average, equities analysts anticipate that Aflac Incorporated will post 6.88 EPS for the current year.

Aflac Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Monday, June 2nd. Shareholders of record on Wednesday, May 21st were paid a $0.58 dividend. This represents a $2.32 annualized dividend and a yield of 2.25%. The ex-dividend date was Wednesday, May 21st. Aflac’s payout ratio is 36.25%.

Aflac Company Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.